Dahl Chase Folders

FOCUS Newsletters and Memos

1	2018, Jan, Update on Reporting Thyroid Cytopathology
2	2016, May, New Reporting System for Urinary Cytology
3	2016, January, Update on Laboratory Evaluation of Thyroid Nodule - Thyroseq®
4	2016, November, Memo FDA Approval for SurePath with the Cobas HPV Test Important Memo To: All Providers From: Richard Riemersma, MD, Medical Director Date: November 10, 2016 Effective Date: December 1, 2016 Re: FDA approval for SurePath™ with the Cobas® HPV Test Dahl-Chase Diagnostic Services is pleased to announce that SurePath™…
5	2015, June, Endometrial Cells
6	2015, April, New Methodology HPV Testing
7	2014, Dec, Update Advanced Beneficiary Notice and Billing
8	2013, March, Lung Carcinoma Molecular Analysis
9	2013, June, Cervical Cancer Screening Update
10	2011, May, Breast Cancer Diagnostic Testing Updates
11	2011, April, Advanced Beneficiary Notice for Pap Tests
12	2010, Oct, Microsatellite Instability Analysis
13	2010, Oct, BRAF V600E Mutation Analysis
14	2009, Sept, Specimen Labeling Policy
15	2009, Sept, K-RAS Mutation Assay
16	2009, Mar, UroVysion FISH
17	2009, FISH For HER2 Gene Amplification